Operating profit before special items increased by 5% year-over-year. Coloplast reaffirmed its FY 2025 guidance of 8%-9% organic revenue growth and an EBIT margin of approximately 28%. The company ...

Ladies and gentlemen, welcome to the Coloplast A/S Q1 2024-'25 Earnings Release Conference Call. I'm Valentina, the Chorus Call operator. [Operator Instructions] The conference must not be ...

Coloplast delivered 8% organic growth and an EBIT margin1 of 27% in Q1, in line with expectations. Reported revenue in DKK grew 6% and included negative impact from the divestment of Skin Care and ...

Investing.com -- Shares of Coloplast (CSE:COLOb) climbed 3.5% as the medical device company reported first-quarter revenue in line with consensus expectations and earnings per share (EPS ...

"Obviously, we're not pleased with the court's opinion, but we understand,” said Janpaul Portal, who is representing MSP ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Key drivers of the global advanced wound management products market include the increasing geriatric population, which is prone to chronic wounds, and the rising prevalence of chronic diseases such as ...